Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

Summary

This study is designed to investigate the efficacy of fluticasone propionate (FP) on ocular symptoms associated with allergic rhinitis (AR).

Timeline

Start

2012-12

Primary completion

2013-02

Completion

2013-02

Outcome

Met primary endpoint

paper The least squares mean difference in the change from baseline of rTOSS was -0.36 (P = .002). PMID 25624132 ↗

paper Fluticasone was statistically significantly more efficacious in reducing the ocular symptoms of AR than placebo. PMID 25624132 ↗

Publications

• Ratner P, Van Bavel J, Mohar D, Jacobs RL, Hampel F, Howland W, Karwal R. Efficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2015 Feb;114(2):141-7. doi: 10.1016/j.anai.2014.11.012.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fluticasone propionate	Other / unclassified	200 ug	Intranasal

Indications